Superworth

Artivion price to free cash flow AORT

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026
n/m
not a meaningful number
Last meaningful
89.3×
Jul 2026
10-year median
100×
10-year range
36.1× to 486×
Peer median
17.6×

Artivion's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Jul 2026, at 89.3×.

On the days it had one over the last ten years, its median was 100×, from 36.1× in Apr 2017 to 486× in Sep 2021.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far89.3×66.9×120×
2025125×87.3×279×
2024108×68.8×125×
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
2021419×175×486×
2020136×55.4×171×
201954.0×47.0×274×
2018214×172×403×
2017356×36.1×371×
201651.3×24.5×67.4×
201529.1×27.6×78.1×
201473.4×17.5×73.4×
201319.7×9.9×20.1×
201214.7×10.4×16.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Artivion's size, closest first, today.

CompanyPrice to free cash flow
AORTArtivionn/m
STAAStaar Surgicaln/m
IRMDIradimed43.7×
BVSBioventus13.3×
CDRECadre16.4×
EYENational Vision30.1×
MOVMovado9.8×
LMATLemaitre Vascular26.2×
INSPInspire Medical Systems17.6×
MDXGMimedxn/m
UFPTUFP Technologiesn/m
Peer median17.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Artivion

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.